Why the study?
Does an activated protein C-dependent thrombin generation assay predict chemotherapy-associated venous thromboembolism in cancer patients?
Does an activated protein C-dependent thrombin generation assay predict chemotherapy-associated venous thromboembolism in cancer patients?
An activated protein C-dependent thrombin generation assay may predict chemotherapy-associated venous thromboembolism in cancer patients.
No takes yet. Share an insight, caveat, or question.
Martini et al. (2011) studied this question.